发明名称 Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals
摘要 Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat cognitive disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such conditions.
申请公布号 US9119851(B2) 申请公布日期 2015.09.01
申请号 US201414314802 申请日期 2014.06.25
申请人 NEUREN PHARMACEUTICALS, LTD. 发明人 Bickerdike Michael John;Guan Jian
分类号 A61K31/498;A61K31/4985;C07D487/04;C07D487/10 主分类号 A61K31/498
代理机构 Borson Law Group, PC 代理人 Borson D. Benjamin;Borson Law Group, PC
主权项 1. A method for relieving or alleviating a symptom of cognitive dysfunction caused by a disease, injury, or condition in a mammal in need thereof, comprising: administering a pharmaceutically effective amount of cyclic Glycyl-2-Allyl Proline (cG-2-AllylP) to said mammal thereby providing relief from the symptom, where said symptom is loss of spatial memory, loss of long-term memory, or loss of novelty recognition.
地址 Auckland NZ